LAG3 and lung carcinoma: The lung cancer model treated with NBTXR3 metal nanoparticles plus microwave irradiation, anti-PD-1, anti-TIGIT and anti-LAG-3 demonstrated increased efficacy compared to a protocol that excluded LAG-3 blockade.